Cardiac troponin T in patients with kidney disease

Area of Science:

• Nephrology
• Cardiology
• Biochemistry

Background:

• Dialysis patients exhibit accelerated atherosclerosis and significantly higher cardiovascular mortality rates compared to the general population.
• Cardiac troponin T (cTnT) is a highly sensitive biomarker for myocardial necrosis, surpassing traditional cardiac enzymes in diagnostic utility.

Purpose of the Study:

• To review the significance of elevated cardiac troponin T (cTnT) in patients with varying degrees of renal failure and different treatment modalities.
• To explore potential causes of elevated cTnT in end-stage renal disease (ESRD) patients without acute coronary events.

Main Methods:

• Literature review of studies examining cardiac troponin T levels in patients with renal failure.
• Analysis of potential mechanisms for elevated cTnT, including decreased clearance, analytical interference, subclinical myocardial ischemia, and cardiac remodeling.

Main Results:

• Elevated cTnT is frequently observed in patients with renal failure, irrespective of treatment modality, even without acute coronary events.
• Decreased clearance or analytical interference from uremic serum are considered unlikely explanations for elevated cTnT.
• Elevated cTnT in ESRD patients is accepted as originating from myocytes, potentially due to subclinical myocardial ischemia, remodeling, or inflammation (uremic pericarditis/myocarditis).

Conclusions:

• Elevated cardiac troponin T in dialysis patients warrants further investigation into underlying cardiac pathology.
• The presence of elevated cTnT in renal failure may indicate subclinical myocardial damage or remodeling, contributing to increased cardiovascular risk.